NCT01736696 - Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions

PsoriasisImmunomodulation

Interventions

DRUG

tofacitinib

5 mg BID For 13 days and once on Day 14

DRUG

tofacitinib

10 mg BID for 13 days and once on Day 14\*

DRUG

tofacitinib

20 mg BID for 13 days and once on Day 14

DRUG

tofacitinib

30 mg BID for 13 days and once on Day 14

DRUG

tofacitinib

60 mg tablet once a day (QD) for 14 days

DRUG

tofacitinib

50 mg tablets two times a day (BID) for 13 days and once on day 14

Trial Locations (1)

Pfizer Investigational Site, Little Rock